Arkolith/Insider Trading/KRBP/Form 4

Bersani Pietro

Chief Executive Officer, DirectorKiromic Biopharma, Inc. (KRBP) · full profile →Form 4 · filed Aug 26, 2024
Net Buying
Open-Market Buys
$7K
Open-Market Sells
$0
Net Open-Market Flow
$7K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2024Buy(P)988$1.93$2K142K
Aug 23, 2024Buy(P)3K$2.20$6K141K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-027784) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML